findmyKOL
Clinical trialNCT04529512UnknownPhase 4Interventional

INtravitreal and Aqueous Dexamethasone Levels After DEXtenza

SponsorNathan SteinleEnrollment40Ocular Disease Requiring Surgery
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A prospective, open-label, interventional study to determine intraocular concentration levels of dexamethasone following use of the DEXTENZA® implant.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • California Retina Consultants

    Paso Robles, California, United States

  • California Retina Consultants

    San Luis Obispo, California, United States

  • California Retina Consultants

    Santa Maria, California, United States

    Nathan Steinle, MD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

DEXTENZA®
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2021
Primary completion
31 Mar 2021
Completion
31 Mar 2021
Last update posted
29 Jan 2021
Registered enrollment
40
Registry id
NCT04529512

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.